A molecular pas de deux controls inflammation
Nature Immunology
April 1, 2013
A molecular mechanism by which immune cells regulate inflammatory responses, which are often associated with diseases such as sepsis, is revealed in a report published online in Nature Immunology this week.
Rama Mallampalli and colleagues find that a molecule called Fbxl2 is present within certain immune cells and this potently arrests the ability of cells to produce inflammatory mediators. However, when cells are exposed to microbial products they engage a second molecule called Fbxo3, which degrades Fbxl2 and thereby allows activation of the cell. The team goes on to synthesize a drug which blocks Fbxo3, thereby maintaining high levels of Fbxl2 that keep cells in an inactive state. This was shown to be beneficial in various mouse models of inflammatory disease. Alterations in the level and function of Fbxl2 and Fbxo3 were found associated with human sepsis and the team note that a natural human mutation in Fbxo3 resulted in weaker inflammatory responses by immune cells.
This study demonstrates an important pathway regulating inflammation in both humans and mice and offers useful molecular insights into how these could be therapeutically targeted.
doi: 10.1038/ni.2565
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature